Our findings establish KCTD10 as a critical regulator of both tumor progression and the tumor environment, highlighting the therapeutic potential of the novel METTL14/KCTD10/β-catenin regulatory axis in lung cancer treatment. This evidence concerns the gene KCTD10 and neoplasm.